Pancreatic Cancer Research

ResearcherPurdue University West LafayetteActive in the last 2 years

Garima Baral

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0074-921X; OpenAlex author ID A5028068833. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2024: 1 paper · 2025: 1 paper · 2026: 1 paper

Papers 3

  1. Activation of PP2A-B56a leads to aberrant EGFR signaling and proliferative phenotypes in PDAC. Co-author DOI 10.1158/1535-7163.mct-25-0970↗
  2. PP2A activation drives aberrant macropinocytosis and cell death in pancreatic ductal adenocarcinoma Co-author DOI 10.1101/2025.07.14.664742↗
  3. KRAS-mediated upregulation of CIP2A promotes suppression of PP2A-B56α to initiate pancreatic cancer development. Co-author DOI 10.1038/s41388-024-03196-w↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Brittany L. Allen-Petersen · 3 shared papers, 2024–2026 · strength 0.61
  2. Claire M. Pfeffer · 2 shared papers, 2025–2026 · strength 0.44
  3. Jennifer P. Morton · 1 shared paper, 2026 · strength 0.22
  4. Luis Solorio · 1 shared paper, 2024 · strength 0.17
  5. Isabel A. English · 1 shared paper, 2024 · strength 0.17
  6. Samantha L. Tinsley · 1 shared paper, 2024 · strength 0.17
  7. Marina Pasca di Magliano · 1 shared paper, 2024 · strength 0.17
  8. Rosalie C. Sears · 1 shared paper, 2024 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.